[1] |
LIN Jiaxin, WEI Ran, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua.
Clinicopathological analysis of adrenal intravascular large B-cell lymphoma
[J]. China Oncology, 2024, 34(11): 1020-1027.
|
[2] |
WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua.
Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
[J]. China Oncology, 2023, 33(9): 809-817.
|
[3] |
CD-Positive Lymphoma Pathology Expert Group.
The standardization of immunohistochemical detection and interpretation of CD30 expression in lymphomas
[J]. China Oncology, 2023, 33(3): 228-234.
|
[4] |
HE Liyuan, WANG Yudong.
Research progress of ALK kinase domain drug resistance mutation and its future countermeasures
[J]. China Oncology, 2022, 32(8): 736-746.
|
[5] |
LIU Yanquan, HU Xiaomei, YIN Yue, LIN Lin, SHEN Jianzhen, CHEN Yuting, TANG Huanwen.
A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder
[J]. China Oncology, 2022, 32(7): 650-656.
|
[6] |
LI Xiaoqiu, CD30 Positive Lymphoma Pathology Expert Group.
Detection of CD30 expression in lymphomas: status and challenges
[J]. China Oncology, 2022, 32(6): 512-518.
|
[7] |
CHEN Guangliang, WU Fangtian, CAO Junning.
Advances in research on EBV positive diffuse large B-cell lymphoma, not otherwise specified
[J]. China Oncology, 2022, 32(3): 258-267.
|
[8] |
JIN Zhengming.
Clinical practice optimization exploration and future prospects of autologous hematopoietic stem cell transplantation for lymphoma
[J]. China Oncology, 2022, 32(2): 161-171.
|
[9] |
HAN Ruxue, LIANG Xiang, MA Xuhui, GUO Wei, WU Yunteng, REN Guoxin.
Characteristics and prognostic analysis of oral mucosal melanoma with lung metastasis
[J]. China Oncology, 2022, 32(12): 1184-1189.
|
[10] |
WU Chunyan , XIE Huikang , LI Yuan .
Interpretation of pleura, pericardium and thymus tumours updates in the WHO classification of thoracic tumours (5th edition)
[J]. China Oncology, 2021, 31(9): 769-774.
|
[11] |
LI Yuan , XIE Huikang , WU Chunyan .
Interpretation of lung tumours in the WHO classification of thoracic tumours (5th edition)
[J]. China Oncology, 2021, 31(7): 574-580.
|
[12] |
HE Hesheng , YANG Yuqiong , LIU Yinhua , JIN Xiaoke , XU Youhai , YAO Junping , LIU Shanhao , YAN Jiawei , HUANG Dongping .
Characteristic analysis of peripheral T-cell lymphoma associated with autoimmune hemolytic anemia
[J]. China Oncology, 2021, 31(2): 121-125.
|
[13] |
LI Lei , WANG Zhi , YOU Chunyuan .
The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report
[J]. China Oncology, 2021, 31(2): 156-160.
|
[14] |
LI Panpan, ZHANG Zhuo.
Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma
[J]. China Oncology, 2021, 31(12): 1194-1201.
|
[15] |
The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center.
The Chinese Expert Consensus Recommendations on Molecular Testing in Endometrial Cancer (2021 edition)
[J]. China Oncology, 2021, 31(11): 1126-1144.
|